Immunogenetic Mechanisms in Behcet's Disease
2 other identifiers
observational
25
1 country
1
Brief Summary
Background: \- Uveitis, the inflammation of the interior of the eye, is responsible for numerous new cases of legal blindness every year. Uveitis can be caused by Beh(SqrRoot)(Beta)et s disease (BD), a chronic inflammatory disorder that can affect the eye, mucous membranes, and other body organs such as the joints, intestinal tract, blood vessels, and central nervous system. Objectives: The purpose of this study is to see how genes affect Beh(SqrRoot)(Beta)et s disease and if there are differences in Beh(SqrRoot)(Beta)et s disease among people of different backgrounds. Eligibility:
- Individuals who have a diagnosis of BD and are enrolled in another NIH study.
- Individuals who are willing to donate blood for the purposes of this research study and who are willing to have their blood stored for possible future/other research purposes. Design:
- As part of the study, blood samples will be drawn from participants when an exacerbation in disease activity occurs and before and after any significant change in treatment for BD.
- No treatments will be provided in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2010
CompletedFirst Submitted
Initial submission to the registry
April 22, 2010
CompletedFirst Posted
Study publicly available on registry
April 23, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2018
CompletedNovember 4, 2019
December 17, 2018
April 22, 2010
November 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Establishing evidence for serum biomarkers associated with BD and establishing demethylation differences between ocular and non-ocular BD participants and controls.
Ongoing
Secondary Outcomes (1)
To explore associations between disease severity and treatment response with observed epigenetic modifications and biomarkers.
Ongoing
Eligibility Criteria
You may qualify if:
- One of the following must be true:
- Participants must have a diagnosis of BD according to the International Study Group for BD criteria or modified Japanese criteria, be enrolled in another NIH study and be willing to donate their blood for the purposes of this research study.
- Participants must be willing to have their blood stored for future/other research.
You may not qualify if:
- Eligible participants who do not wish to donate their blood sample or undergo a blood draw for the purposes of this research study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004 Mar;111(3):491-500; discussion 500. doi: 10.1016/j.ophtha.2003.06.014.
PMID: 15019324BACKGROUNDChamberlain MA. Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977 Dec;36(6):491-99. doi: 10.1136/ard.36.6.491.
PMID: 596943BACKGROUNDJankowski J, Crombie I, Jankowski R. Behcet's syndrome in Scotland. Postgrad Med J. 1992 Jul;68(801):566-70. doi: 10.1136/pgmj.68.801.566.
PMID: 1437955BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hatice N Sen, M.D.
National Eye Institute (NEI)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2010
First Posted
April 23, 2010
Study Start
April 15, 2010
Study Completion
December 17, 2018
Last Updated
November 4, 2019
Record last verified: 2018-12-17